Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors

Biochemical and Biophysical Research Communications

Volumn 282, Issue 1, 2001, Pages 173-179

  Okada, Naoki ^a   Mori, Kohei ^a   Saito, Tomomi ^a   Fujita, Takuya ^a   Yamamoto, Akira ^a   Tsukada, Yukiko ^b   Nakagawa, Shinsaku ^b   Mayumi, Tadanori ^b   Mizuguchi, Hiroyuki ^c   Hayakawa, Takao ^c  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Adenovirus vector; Arg Gly Asp sequence; Coxsackie adenovirus receptor; Dendritic cell; Fiber mutant; Gene immunotherapy; v integrin

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA GALACTOSIDASE; GENE PRODUCT; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS; DENDRITIC CELL; DOSE RESPONSE; ENZYME ACTIVITY; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION; VIRUS MUTANT;

ADENOVIRIDAE; MURINAE;

EID: 0034816695     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4527     Document Type: Article

References (29)

1. Dendritic cells: Antigen presentation, accessory function and clinical relevance
2. New insights into the mobilization and phagocytic activity of dendritic cells
3. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
4. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
5. Induction of antitumor immunity using bone marrow-generated dendritic cells
6. Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
7. Dendritic cell-based immunotherapy of prostate cancer: Immune monitoring of a phase II clinical trial
8. The biochemistry and cell biology of antigen processing and presentation
9. Gene therapy for metabolic disorders
10. Gene therapy: Adenovirus vectors
11. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
12. 5 promote adenovirus internalization but not virus attachment
13. A comparison of gene transfer methods in human dendritic cells
14. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob
15. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules
16. Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin
17. Successive generation of antigen-presenting, dendritic cell lines from murine epidermis
18. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method
19. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors
20. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12
21. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination
22. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
23. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas
24. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication
25. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells
26. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
27. + dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity
28. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector
29. High efficiency adenovirus-mediated gene transfer to human dendritic cells